buthionine sulfoximine has been researched along with cyclic gmp in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 7 (87.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Maher, P; Schubert, D | 1 |
| Inoue, R; Nakamizo, T; Sawada, H; Shibasaki, H; Shimohama, S; Urushitani, M | 1 |
| Anggård, EE; Carrier, MJ; Desai, KM; Laight, DW | 1 |
| Haramaki, N; Haramaki, R; Ikeda, H; Imaizumi, T; Kanaya, S; Katoh, A; Murohara, T; Shintani, S; Takajo, Y | 1 |
| Abukhalaf, IK; Bayorh, MA; Eatman, D; Ganafa, AA; Silvestrov, N; Socci, RR | 1 |
| Chen, J; Connolly, EC; Ronnett, GV; Tu, Y | 1 |
| Masood, A; Mustafa, SJ; Nadeem, A; O'Donnell, JM | 1 |
| Banday, AA; Lokhandwala, MF | 1 |
8 other study(ies) available for buthionine sulfoximine and cyclic gmp
| Article | Year |
|---|---|
Requirement for cGMP in nerve cell death caused by glutathione depletion.
Topics: Animals; Apoptosis; Buthionine Sulfoximine; Calcium; Carbon Monoxide; Cell Line; Cell Membrane Permeability; Cerebral Cortex; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Enzyme Activation; Enzyme Inhibitors; Glutamic Acid; Glutathione; Guanylate Cyclase; Hippocampus; Mice; Neurons; Nitric Oxide; Signal Transduction | 1997 |
Neuroprotective effect of cyclic GMP against radical-induced toxicity in cultured spinal motor neurons.
Topics: Animals; Buthionine Sulfoximine; Cells, Cultured; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Embryo, Mammalian; Enzyme Inhibitors; Hydrogen Peroxide; Motor Neurons; Oxidants; Rats; Reactive Oxygen Species; Spinal Cord | 2000 |
Endothelial dysfunction accompanies a pro-oxidant, pro-diabetic challenge in the insulin resistant, obese Zucker rat in vivo.
Topics: Acetylcholine; Animals; Antioxidants; Area Under Curve; Body Weight; Buthionine Sulfoximine; Cyclic GMP; Diabetes Mellitus, Type 2; Endothelium, Vascular; Enzyme Inhibitors; Hemodynamics; Hydroquinones; Insulin Resistance; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Obesity; Oxidants; Rats; Rats, Zucker | 2000 |
Long-term smoking causes nitroglycerin resistance in platelets by depletion of intraplatelet glutathione.
Topics: Animals; Blood Platelets; Buthionine Sulfoximine; Coronary Thrombosis; Cyclic GMP; Female; Glutathione; Humans; Male; Nitric Oxide Donors; Nitroglycerin; Oxidation-Reduction; Platelet Aggregation; Rabbits; Smoking | 2001 |
Effect of losartan on oxidative stress-induced hypertension in Sprague-Dawley rats.
Topics: Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Aorta; Biomarkers; Blood Pressure; Buthionine Sulfoximine; Cyclic AMP; Cyclic GMP; Dinoprost; Disease Models, Animal; Enzyme Inhibitors; Epoprostenol; F2-Isoprostanes; Glutathione; Heart Rate; Hypertension; Kidney; Losartan; Male; Models, Cardiovascular; Nitric Oxide; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxides; Thromboxane A2; Treatment Outcome | 2003 |
Heme oxygenase-2 protects against glutathione depletion-induced neuronal apoptosis mediated by bilirubin and cyclic GMP.
Topics: Animals; Apoptosis; Bilirubin; Buthionine Sulfoximine; Cells, Cultured; Cyclic GMP; Enzyme Inhibitors; Glutathione; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Membrane Proteins; Mice; Mice, Knockout; Neuroprotective Agents; Olfactory Receptor Neurons; Stem Cells | 2005 |
Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice.
Topics: Animals; Antioxidants; Anxiety; Behavior, Animal; Buthionine Sulfoximine; Cells, Cultured; Cerebral Cortex; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 2; Disease Models, Animal; Lipid Peroxides; Male; Maze Learning; Mice; Mice, Inbred ICR; NADPH Oxidases; Neurons; Oxidative Stress; Phosphodiesterase Inhibitors; Phosphorylation; Rats; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction | 2008 |
Loss of biphasic effect on Na/K-ATPase activity by angiotensin II involves defective angiotensin type 1 receptor-nitric oxide signaling.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Buthionine Sulfoximine; Cyclic GMP; Cyclic N-Oxides; Enzyme Inhibitors; Focal Adhesion Kinase 2; Hypertension, Renal; Kidney Tubules, Proximal; Male; Mitogen-Activated Protein Kinases; Nitric Oxide; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Signal Transduction; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sodium-Potassium-Exchanging ATPase; Spin Labels; Tetrazoles; Vasoconstrictor Agents | 2008 |